Amgen gained the most in seven months after a Wall Street analyst upgraded the stock, citing the potential of its experimental weight-loss drug https://t.co/AndDO7HKPs— Bloomberg (@business) October 11, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


